{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:01:53Z","timestamp":1792706513876,"version":"4.5.0"},"reference-count":25,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2015,7,16]],"date-time":"2015-07-16T00:00:00Z","timestamp":1437004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0133236","type":"journal-article","created":{"date-parts":[[2015,7,16]],"date-time":"2015-07-16T17:44:44Z","timestamp":1437068684000},"page":"e0133236","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":31,"title":["Dynamic Changes of Post-Translationally Modified Forms of CXCL10 and Soluble DPP4 in HCV Subjects Receiving Interferon-Free Therapy"],"prefix":"10.1371","volume":"10","author":[{"given":"Eric G.","family":"Meissner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00e9mie","family":"Decalf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armanda","family":"Casrouge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Masur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam","family":"Kottilil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew L.","family":"Albert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darragh","family":"Duffy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,7,16]]},"reference":[{"issue":"Suppl 1","key":"ref1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/liv.12423","article-title":"HCV direct-acting antiviral agents: the best interferon-free combinations","volume":"34","author":"R Schinazi","year":"2014","journal-title":"Liver international: official journal of the International Association for the Study of the Liver"},{"issue":"6","key":"ref2","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1001\/jama.2014.7085","article-title":"Treatment of hepatitis C: a systematic review","volume":"312","author":"A Kohli","year":"2014","journal-title":"JAMA: the journal of the American Medical Association"},{"issue":"8","key":"ref3","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1172\/JCI75938","article-title":"Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcome","volume":"124","author":"EG Meissner","year":"2014","journal-title":"J Clin Invest"},{"issue":"3","key":"ref4","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jhep.2014.05.043","article-title":"Restoration of HCV-specific CD8+ T cell function by interferon-free therapy","volume":"61","author":"B Martin","year":"2014","journal-title":"J Hepatol"},{"issue":"2","key":"ref5","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/liv.12748","article-title":"Continued value in understanding viral kinetic decline during interferon-free therapy for HCV","volume":"35","author":"EG Meissner","year":"2015","journal-title":"Liver international: official journal of the International Association for the Study of the Liver"},{"issue":"6193","key":"ref6","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1126\/science.1257737","article-title":"Medicine. Hepatitis C can be cured globally, but at what cost?","volume":"345","author":"A Hill","year":"2014","journal-title":"Science"},{"issue":"5","key":"ref7","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1002\/hep.22500","article-title":"Intrahepatic levels of CXCR3-associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis C","volume":"48","author":"M Zeremski","year":"2008","journal-title":"Hepatology"},{"issue":"4","key":"ref8","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.jhep.2013.06.001","article-title":"Independent, parallel pathways to CXCL10 induction in HCV-infected hepatocytes","volume":"59","author":"J Brownell","year":"2013","journal-title":"J Hepatol"},{"issue":"5","key":"ref9","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jhep.2007.04.009","article-title":"The role of CCR5\/CXCR3 expressing CD8+ cells in liver damage and viral control during persistent hepatitis C virus infection","volume":"47","author":"JR Larrubia","year":"2007","journal-title":"J Hepatol"},{"issue":"10","key":"ref10","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1365-2893.2006.00838.x","article-title":"The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection","volume":"14","author":"M Zeremski","year":"2007","journal-title":"J Viral Hepat"},{"issue":"3","key":"ref11","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jhep.2010.12.033","article-title":"Induction of CXCR3- and CCR5-associated chemokines during acute hepatitis C virus infection","volume":"55","author":"M Zeremski","year":"2011","journal-title":"J Hepatol"},{"issue":"4","key":"ref12","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/jgh.12462","article-title":"Positioning of leukocyte subsets in the portal and lobular compartments of hepatitis C virus-infected liver correlates with local chemokine expression","volume":"29","author":"N Nguyen","year":"2014","journal-title":"Journal of gastroenterology and hepatology"},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1136\/gut.2005.074062","article-title":"Association of pretreatment serum interferon gamma inducible protein 10 levels with sustained virological response to peginterferon plus ribavirin therapy in genotype 1 infected patients with chronic hepatitis C","volume":"55","author":"M Diago","year":"2006","journal-title":"Gut"},{"issue":"6","key":"ref14","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1002\/hep.21407","article-title":"IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection","volume":"44","author":"M Lagging","year":"2006","journal-title":"Hepatology"},{"issue":"7","key":"ref15","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1086\/507307","article-title":"Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection","volume":"194","author":"AI Romero","year":"2006","journal-title":"J Infect Dis"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/hep.24056","article-title":"Quantitation of pretreatment serum interferon-gamma-inducible protein-10 improves the predictive value of an IL28B gene polymorphism for hepatitis C treatment response","volume":"53","author":"JM Darling","year":"2011","journal-title":"Hepatology"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1053\/j.gastro.2011.09.039","article-title":"Serum level of IP-10 increases predictive value of IL28B polymorphisms for spontaneous clearance of acute HCV infection","volume":"142","author":"S Beinhardt","year":"2012","journal-title":"Gastroenterology"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1365-2249.2011.04488.x","article-title":"Discrimination of agonist and antagonist forms of CXCL10 in biological samples","volume":"167","author":"A Casrouge","year":"2012","journal-title":"Clinical and experimental immunology"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1172\/JCI40594","article-title":"Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV","volume":"121","author":"A Casrouge","year":"2011","journal-title":"J Clin Invest"},{"issue":"2","key":"ref20","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/hep.27139","article-title":"Truncated CXCL10 is associated with failure to achieve spontaneous clearance of acute hepatitis C infection","volume":"60","author":"A Riva","year":"2014","journal-title":"Hepatology"},{"issue":"2","key":"ref21","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cyto.2013.04.016","article-title":"CXCL10 antagonism and plasma sDPPIV correlate with increasing liver disease in chronic HCV genotype 4 infected patients","volume":"63","author":"D Ragab","year":"2013","journal-title":"Cytokine"},{"issue":"2","key":"ref22","doi-asserted-by":"crossref","first-page":"e56991","DOI":"10.1371\/journal.pone.0056991","article-title":"Impact of soluble CD26 on treatment outcome and hepatitis C virus-specific T cells in chronic hepatitis C virus genotype 1 infection","volume":"8","author":"J Soderholm","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"ref23","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nbt.1641","article-title":"Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations","volume":"28","author":"DM Rissin","year":"2010","journal-title":"Nat Biotechnol"},{"issue":"8","key":"ref24","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1001\/jama.2013.109309","article-title":"Sofosbuvir and ribavirin for hepatitis C genotype 1 in patients with unfavorable treatment characteristics: a randomized clinical trial","volume":"310","author":"A Osinusi","year":"2013","journal-title":"JAMA: the journal of the American Medical Association"},{"issue":"9","key":"ref25","doi-asserted-by":"crossref","first-page":"634","DOI":"10.7326\/M14-1211","article-title":"Re-treatment of Chronic Hepatitis C Virus Genotype 1 Infection After Relapse: An Open-Label Pilot Study","volume":"161","author":"A Osinusi","year":"2014","journal-title":"Ann Intern Med"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0139818","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2015,9,29]],"date-time":"2015-09-29T00:00:00Z","timestamp":1443484800000}}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0133236","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T01:06:11Z","timestamp":1717981571000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0133236"}},"subtitle":[],"editor":[{"given":"Stephen J","family":"Polyak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,7,16]]},"references-count":25,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2015,7,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0133236","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,16]]}}}